CervoMed Inc.CRVONASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-15.5%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-15.5%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 14.37% |
| 2024 | 40.61% |
| 2023 | 204.77% |
| 2022 | -71.27% |
| 2021 | 15.54% |
| 2020 | 33.31% |
| 2019 | -21.62% |
| 2018 | -0.40% |
| 2017 | -27.95% |
| 2016 | 240.76% |